Published in J Lipid Res on August 01, 1995
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell (1993) 4.76
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
Sexual transmission of hepatitis C virus. Lancet (1993) 4.27
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem (1995) 3.33
Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem (1982) 2.92
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol (2000) 2.66
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A (1994) 2.52
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (1996) 2.35
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol (1994) 2.26
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A (1998) 2.17
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A (1995) 2.00
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79
Polydactyly and ectopic ZPA formation in Alx-4 mutant mice. Development (1997) 1.77
Modern theories of metabolic control and their applications (review). Biosci Rep (1984) 1.75
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74
Control of gluconeogenesis in rat liver cells. Flux control coefficients of the enzymes in the gluconeogenic pathway in the absence and presence of glucagon. Biochem J (1986) 1.70
Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem (1994) 1.69
Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest (1998) 1.65
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61
Control of mitochondrial respiration. FEBS Lett (1983) 1.61
FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol (2001) 1.60
Intramitochondrial and extramitochondrial concentrations of adenine nucleotides and inorganic phosphate in isolated hepatocytes from fasted rats. Eur J Biochem (1978) 1.58
A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology (1993) 1.57
Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol (2001) 1.55
Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52
Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice. Gastroenterology (2000) 1.50
Insulin-like growth factor-I in liver cirrhosis. J Hepatol (1997) 1.50
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy (1998) 1.44
Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. J Biol Chem (1985) 1.43
Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice. J Hepatol (2001) 1.43
Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes. Hepatology (1995) 1.43
Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr (1999) 1.42
Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology (1992) 1.42
Pathogenesis and medical therapy of primary sclerosing cholangitis. Any news? Eur J Gastroenterol Hepatol (1999) 1.40
The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab (2011) 1.39
Oral calcium phosphate: a new therapy for Crigler-Najjar disease? Gastroenterology (1997) 1.39
Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest (1995) 1.39
Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology (1985) 1.39
Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest (1996) 1.37
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta (1995) 1.35
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol (1991) 1.35
Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology (1997) 1.33
Intracellular compartmentation and control of alanine metabolism in rat liver parenchymal cells. Eur J Biochem (1982) 1.32
Plasmodium berghei: gametocyte production, DNA content, and chromosome-size polymorphisms during asexual multiplication in vivo. Exp Parasitol (1989) 1.32
Characterization of isolated rat-liver cells made permeable with filipin. Eur J Biochem (1981) 1.32
Variation in Cobb angle measurements in scoliosis. Skeletal Radiol (1994) 1.29
Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest (1989) 1.29
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis (2007) 1.28
Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy. Gastrointest Endosc (1997) 1.28
Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res (1996) 1.27
Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology (2000) 1.26
Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest (1994) 1.26
Enzymatic conversion of bilirubin monoglucuronide to diglucuronide by rat liver plasma membranes. J Biol Chem (1977) 1.26
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol (1998) 1.24
Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J (1999) 1.23
Molecular aspects of hepatobiliary transport. Am J Physiol (1997) 1.23
Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology (2001) 1.22
The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol (1993) 1.21
Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology (1987) 1.19
ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol (1999) 1.17
Plasma-membrane transport of alanine is rate-limiting for its metabolism in rat-liver parenchymal cells. FEBS Lett (1980) 1.17
Control of gluconeogenesis in rat liver cells. I. Kinetics of the individual enzymes and the effect of glucagon. J Biol Chem (1983) 1.15
Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology (1990) 1.14
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects. J Intern Med (2009) 1.13
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology (1996) 1.13
Biosynthesis and intracellular transport of alpha-glucosidase and cathepsin D in normal and mutant human fibroblasts. Eur J Biochem (1985) 1.13
The isomerisation of bilirubin monoglucuronide. Clin Chim Acta (1973) 1.12
Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology (1998) 1.12
Delipidation and reactivation of UDPglucuronosyltransferase from rat liver. Biochim Biophys Acta (1975) 1.11
The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl (1999) 1.10
Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion (1993) 1.09
ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. Am J Physiol (1990) 1.08
A scanning electron microscopic study of biliary stent materials. Gastrointest Endosc (2000) 1.06
Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. Gastroenterology (1987) 1.06
The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther (1994) 1.06
Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J (1992) 1.06
Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology (1997) 1.05
Isolation and characterization of a precursor form of lysosomal alpha-glucosidase from human urine. Eur J Biochem (1984) 1.05
Factors determining the relative contribution of the adenine-nucleotide translocator and the ADP-regenerating system to the control of oxidative phosphorylation in isolated rat-liver mitochondria. Eur J Biochem (1984) 1.05
Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1996) 1.04
Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem J (2001) 1.04
Microencapsulation: its application in nutrition. Proc Nutr Soc (2001) 1.04
Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology (1996) 1.03
Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J (1997) 1.03